Viking Therapeutics (VKTX)
Develops clinical-stage therapies for obesity, metabolic and endocrine disorders.
$37.05
vs last close+6.94 (+23.05%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 36 days
EPS estimate
−$1.07
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported−$0.32−$0.41−$0.58−$0.81−$1.38−$1.37−$1.10Pending
Estimate−$0.28−$0.34−$0.44−$0.70−$0.89−$1.01−$1.23−$1.07
Surprise−14.3%−20.6%−31.8%−15.7%−55.1%−35.6%+10.6%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported———————Pending
Estimate————$1.9M———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.95 | — | — |
| Sep 2028 | −$0.91 | — | — |
| Jun 2028 | −$0.84 | — | — |
| Mar 2028 | −$0.73 | — | — |
| Dec 2027 | −$0.82 | — | — |
| Sep 2027 | −$0.85 | — | — |
| Jun 2027 | −$0.90 | — | — |
| Mar 2027 | −$1.01 | — | — |
| Dec 2026 | −$1.10 | — | — |
| Oct 2026 | −$1.07 | — | — |
| Jul 2026 | −$1.23 | −$1.10 | +10.6% |
| Apr 2026 | −$1.01 | −$1.37 | −35.6% |
| Feb 2026 | −$0.89 | −$1.38 | −55.1% |
| Oct 2025 | −$0.70 | −$0.81 | −15.7% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.95 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.91 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.84 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.73 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.82 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.85 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.90 | — | — | $0 | — | — | — |
| Mar 2027 | −$1.01 | — | — | $0 | — | — | — |
| Dec 2026 | −$1.10 | — | — | $0 | — | — | — |
| Oct 28, 2026 | −$1.07 | — | — | $0 | — | — | — |
| Jul 29, 2026 | −$1.23 | −$1.10 | +10.6% | — | — | — | −1.0% |
| Apr 29, 2026 | −$1.01 | −$1.37 | −35.6% | — | — | — | −0.5% |
| Feb 11, 2026 | −$0.89 | −$1.38 | −55.1% | $1.9M | — | — | +6.8% |
| Oct 22, 2025 | −$0.70 | −$0.81 | −15.7% | — | — | — | +8.0% |
| Jul 23, 2025 | |||||||
| Apr 23, 2025 | |||||||
| Feb 5, 2025 | |||||||
| Oct 23, 2024 | |||||||
| Jul 24, 2024 | |||||||
| Apr 24, 2024 | |||||||
| Feb 7, 2024 | |||||||
| Oct 25, 2023 | |||||||
| Jul 26, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Feb 8, 2023 | |||||||
| Oct 26, 2022 | |||||||
| Jul 27, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Feb 17, 2021 | |||||||
| Oct 28, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 2, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 21, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 13, 2015 |